TRDA R&D to Revenue

Entrada Therapeutics Inc · R&D to Revenue

TRDA logo

TRDA R&D to Revenue

Latest reported559.65%
TRDA FY R&D/Revenue (0.00% → 559.65%)
High-resolution chart · PNG

TRDA r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Entrada Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
559.6515%
59.4482%
77.4217%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.